1. Home
  2. SGA vs CPIX Comparison

SGA vs CPIX Comparison

Compare SGA & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Saga Communications Inc. (FL)

SGA

Saga Communications Inc. (FL)

HOLD

Current Price

$9.76

Market Cap

73.7M

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$5.91

Market Cap

73.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGA
CPIX
Founded
1986
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.7M
73.6M
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
SGA
CPIX
Price
$9.76
$5.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.2K
1.8M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
9.05%
N/A
EPS Growth
N/A
58.70
EPS
N/A
N/A
Revenue
$124,829,000.00
$42,010,949.00
Revenue This Year
$6.74
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.65
16.75
52 Week Low
$9.90
$1.85
52 Week High
$14.27
$6.27

Technical Indicators

Market Signals
Indicator
SGA
CPIX
Relative Strength Index (RSI) 24.87 76.12
Support Level N/A $2.81
Resistance Level $12.02 $6.04
Average True Range (ATR) 0.31 0.37
MACD -0.07 0.09
Stochastic Oscillator 0.51 97.25

Price Performance

Historical Comparison
SGA
CPIX

About SGA Saga Communications Inc. (FL)

Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: